In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates

被引:8
|
作者
Zaoutis, T
Moore, LS
Furness, K
Klein, JD
机构
[1] Alfred I duPont Hosp Children, Div Pediat Infect Dis, Wilmington, DE 19899 USA
[2] Christiana Hosp, Christiana Care Hlth Syst, Infect Dis Lab, Newark, DE USA
关键词
D O I
10.1128/AAC.45.7.1952-1954.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of meropenem, linezolid, quinupristin dalfopristin, vancomycin, and penicillin against 130 clinical isolates of group C and G streptococci, including vancomycin-tolerant isolates, were evaluated. Meropenem, linezolid, quinupristin-dalfopristin, vancomycin, and penicillin MICs at which 90% of the isolates were inhibited were 0.06, 2.0, 0.25, 0.5, and less than or equal to0.016 mug/ml, respectively. Meropenem, linezolid, quinupristin-dalfopristin, and penicillin were active against group C and G streptococci, including vancomycin-resistant strains.
引用
收藏
页码:1952 / 1954
页数:3
相关论文
共 44 条